Pt(IV)-PROTAC Complexes with Synergistic Antitumor Activity and Enhanced Membrane Permeability

A class of Pt(IV)-PROTAC complexes was designed and synthesized with dual aims of inducing DNA strand damage and inhibiting DNA repair. These complexes showed good antiproliferative activity against a range of cancer cell lines. Enhanced intracellular uptake of platinum and PROTAC was observed. Multiple mechanisms of action were identified, including the induction of DNA damage, disruption of DNA repair, and activation of mitochondrial-dependent apoptosis. One of the Pt(IV)-PROTACs, <b>CW-2</b>, showed excellent antitumor activity in a xenograft mouse model. These results suggest that Pt(IV)-PROTAC represents a promising strategy for the development of novel antitumor therapeutics.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2025-04-04
DOI
https://doi.org/10.1021/acs.jmedchem.4c02909
Citations
10
Primary Topic
Protein Degradation and Inhibitors
Type
article
Field-Weighted Citation Impact
8.06

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pt(IV)-PROTAC Complexes with Synergistic Antitumor Activity and Enhanced Membrane Permeability

Yong Zou, Ming Yan, Xue‐Jing Zhang, Chang‐Jiu Li et al.
10 citations
Journal of Medicinal Chemistry
Protein Degradation and Inhibitors
8.06
article

Pt(IV)-PROTAC Complexes with Synergistic Antitumor Activity and Enhanced Membrane Permeability

Yong Zou, Ming Yan, Xue‐Jing Zhang, Chang‐Jiu Li, Shan Xu, Jiahui Shi, Z. Q. Zou
article en
10 citations

Abstract

A class of Pt(IV)-PROTAC complexes was designed and synthesized with dual aims of inducing DNA strand damage and inhibiting DNA repair. These complexes showed good antiproliferative activity against a range of cancer cell lines. Enhanced intracellular uptake of platinum and PROTAC was observed. Multiple mechanisms of action were identified, including the induction of DNA damage, disruption of DNA repair, and activation of mitochondrial-dependent apoptosis. One of the Pt(IV)-PROTACs, <b>CW-2</b>, showed excellent antitumor activity in a xenograft mouse model. These results suggest that Pt(IV)-PROTAC represents a promising strategy for the development of novel antitumor therapeutics.

Journal of Medicinal ChemistryVol. 68(8)
Sun Yat-sen University (CN), Drug Discovery Laboratory (Norway) (NO)
Natural Science Foundation of Guangdong Province, Guangdong Provincial Key Laboratory of Construction Foundation
Openalex Percentile: Top 2%
Protein Degradation and Inhibitors
8.06
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.